Navigation Links
MannKind to Present at the Piper Jaffray Healthcare Conference
Date:11/20/2007

VALENCIA, Calif., Nov. 20 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Piper Jaffray Healthcare Conference on November 27, 2007 at 10:30 AM ET at the Pierre Hotel in New York, NY.

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of the presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. MannKind to Present at the UBS Global Life Sciences Conference
2. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
3. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
4. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
5. Avicena Group to Present at Noble Financial Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CEL-SCI to Present at the Noble Financial Conference
10. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., The New York investment...Ltd (ASX:NEU) has agreed an AU$6.7 mil convertible...investor. The private placement was arranged by KT...d advisor. , New York (PR... investment bank KTA Capital, LLC ("KTA Capit...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedthatithasreceivednoticefrom,theNasdaqSto...,suspendedasofNovember30,2009andaForm25-NSEwillbef...illremovedeCODE,scommonstock,fromlistingonNasdaq,u...lificationsPanel.Thecompanyhasfiledsuchanappeal,wh...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
(Date:11/24/2009)...,, SHANGHAI,Nov.24/PRNewswire-Asia/--Shangha...nistration(SFDA)hasapprovedthe,investigationalnewd...n),aninnovativeinsulinformulationtotreatdiabetes.T...eIclinicalstudy. , Diabetesisadisordercharact...plicationsofdiabetesoftenresultinseveremicro-and,m...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
... , , , Multiporator / Electroporat... , , Transformation Prot...002 , , , , , , ... Microorganism , Actinobacillus pleu...ell type , Bacteria, gram negative, ...
... , , , Multiporator , , ,... Transfection Protocol , Proto..., , , , , , , , ... 721.221, EBV transfected B cell line, MHC class... MHC class II positive, , , ...
... , , , Multiporator , , ,... Transfection Protocol , Proto..., , , , , , , , ... 721.174, EBV transfected B cell line, MHC class..., , , Transfection w...
Other Biology Technology:Actinobacillus pleuropneumoniae 2721.221 2721.174 2721.174 3
(Date:11/26/2009)... Whitehead researchers have developed a new type o...fic genes and proteins used by pathogens, accordin...ell cultures genes are present in two copies: one ... Gene inactivation by mutation is therefore ineffi...cond copy usually remains active and takes over. ,...
(Date:11/25/2009)...omach, may be used to boost resistance to, or slow...ool of Medicine researchers report in a study publ...ience . , Parkinson,s disease is caused by a deg...dbrain known as the substantia nigra, which is res...ion of dopamine in late-stage Parkinson,s causes s...
(Date:11/25/2009)...is the linchpin of the environment, where atmosphe... many students see soil as "just dirt" a place to...tors are challenged with the task of helping stude...ce of soil in the environment. , A collaborativ...rs at University of Nebraska-Lincoln, Oregon State...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 1New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 3New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 4The way you eat may affect your risk for breast cancer 9464 1The way you eat may affect your risk for breast cancer 9464 2The way you eat may affect your risk for breast cancer 9464 3Restoring a natural root signal helps to fight a major corn pest 9462 1Restoring a natural root signal helps to fight a major corn pest 9462 2Restoring a natural root signal helps to fight a major corn pest 9462 3
... COLD SPRING HARBOR, N.Y. Combining the specifi...th the versatility of lentiviral vectors gives res...gene function both in vivo and in vitro. This mon....cshprotocols.org/TOCs/toc8_08.dtl ) features a pa....edu/faculty/faculty_details.php?id=54 ) and colle...
...Basel, 4 August 2008. New data from studies presen...exico City have provided unprecedented insight int...sulfonate (EMS). The formation of the EMS impurit...f mesylate salts, which are contained in over 40 d...s were designed to determine the impact of elevate...
... ARTICLE #1 FOR IMMEDIATE RELEASE , New imaging ...h painting, Analytical Chemistry , European res... new imaging technique to reveal with unprecedente...it of a woman hidden underneath one of the fabled ...d provide new insights into the hidden details of ...
Other Biology News:Landmark studies assess risk of exposure to elevated levels of EMS confirm clear toxicity threshold 2American Chemical Society's Weekly PressPac -- July 30, 2008 2American Chemical Society's Weekly PressPac -- July 30, 2008 3American Chemical Society's Weekly PressPac -- July 30, 2008 4American Chemical Society's Weekly PressPac -- July 30, 2008 5American Chemical Society's Weekly PressPac -- July 30, 2008 6
Standard and Modified Oligonucleotides Service from Yorkshire Bioscience Ltd
...20 years of expertise in the field of Enzyme-Linke...he most powerful systems on the market. Freedom EV...requiring incubation and washing steps. The inte...aker incubators, reader,washer), all controlled by...
...d Choice Microsphere/Microarray Stabilizer is a is...lus Stabilizer. This product is an aqueous soluti...er (phosphate buffered saline), pH 6.6 - 7.2. Thi...othiazolone and 0.02% bromonitrodioxane as a prese...
Rabbit Anti-JKK / SEK1 / MKK4, phospho Antibody, Unconjugated from MBL International
Biology Products: